These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38539181)

  • 1. Implementation of post-discharge malaria chemoprevention (PDMC) in Benin, Kenya, Malawi, and Uganda: stakeholder engagement meeting report.
    Hill J;
    Malar J; 2024 Mar; 23(1):89. PubMed ID: 38539181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-discharge malaria chemoprevention in children admitted with severe anaemia in malaria-endemic settings in Africa: a systematic review and individual patient data meta-analysis of randomised controlled trials.
    Phiri KS; Khairallah C; Kwambai TK; Bojang K; Dhabangi A; Opoka R; Idro R; Stepniewska K; van Hensbroek MB; John CC; Robberstad B; Greenwood B; Kuile FOT
    Lancet Glob Health; 2024 Jan; 12(1):e33-e44. PubMed ID: 38097295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial.
    Kwambai TK; Dhabangi A; Idro R; Opoka R; Kariuki S; Samuels AM; Desai M; van Hensbroek MB; John CC; Robberstad B; Wang D; Phiri K; Ter Kuile FO
    Trials; 2018 Nov; 19(1):610. PubMed ID: 30400934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of postdischarge malaria chemoprevention in preschool children treated for severe anaemia in Malawi, Kenya, and Uganda: A cost-effectiveness analysis.
    Kühl MJ; Gondwe T; Dhabangi A; Kwambai TK; Mori AT; Opoka R; John CC; Idro R; Ter Kuile FO; Phiri KS; Robberstad B
    EClinicalMedicine; 2022 Oct; 52():101669. PubMed ID: 36313146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial.
    Gondwe T; Robberstad B; Mukaka M; Lange S; Blomberg B; Phiri K
    BMC Pediatr; 2018 Jul; 18(1):238. PubMed ID: 30029620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    Taylor SM; Korwa S; Wu A; Green CL; Freedman B; Clapp S; Kirui JK; O'Meara WP; Njuguna FM
    PLoS Med; 2022 Oct; 19(10):e1004104. PubMed ID: 36215323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria Chemoprevention in the Postdischarge Management of Severe Anemia.
    Kwambai TK; Dhabangi A; Idro R; Opoka R; Watson V; Kariuki S; Kuya NA; Onyango ED; Otieno K; Samuels AM; Desai MR; Boele van Hensbroek M; Wang D; John CC; Robberstad B; Phiri KS; Ter Kuile FO
    N Engl J Med; 2020 Dec; 383(23):2242-2254. PubMed ID: 33264546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin-based combination therapy for treating uncomplicated malaria.
    Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data.
    Fernandes S; Were V; Gutman J; Dorsey G; Kakuru A; Desai M; Kariuki S; Kamya MR; Ter Kuile FO; Hanson K
    Lancet Glob Health; 2020 Dec; 8(12):e1512-e1523. PubMed ID: 33137287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent preventive therapy for malaria with monthly artemether-lumefantrine for the post-discharge management of severe anaemia in children aged 4-59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial.
    Phiri K; Esan M; van Hensbroek MB; Khairallah C; Faragher B; ter Kuile FO
    Lancet Infect Dis; 2012 Mar; 12(3):191-200. PubMed ID: 22172305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-discharge malaria chemoprevention (PMC) in Malawi: caregivers` acceptance and preferences with regard to delivery methods.
    Svege S; Kaunda B; Robberstad B; Nkosi-Gondwe T; Phiri KS; Lange S
    BMC Health Serv Res; 2018 Jul; 18(1):544. PubMed ID: 29996833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent preventive treatment for malaria in infants.
    Esu EB; Oringanje C; Meremikwu MM
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD011525. PubMed ID: 34273901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
    Barsosio HC; Madanitsa M; Ondieki ED; Dodd J; Onyango ED; Otieno K; Wang D; Hill J; Mwapasa V; Phiri KS; Maleta K; Taegtmeyer M; Kariuki S; Schmiegelow C; Gutman JR; Ter Kuile FO
    Lancet; 2024 Jan; 403(10424):365-378. PubMed ID: 38224710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
    Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO
    Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis.
    Roh ME; Kuile FOT; Rerolle F; Glymour MM; Shiboski S; Gosling R; Gutman J; Kakuru A; Desai M; Kajubi R; L'Ianziva A; Kamya MR; Dorsey G; Chico RM
    Lancet Glob Health; 2020 Jul; 8(7):e942-e953. PubMed ID: 32562650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.